{
    "abstract": "Although outbreaks of Hand, Foot, and Mouth Disease (HFMD) in young children have long been recognized worldwide, the occurrence of rare and life-threatening neurological, respiratory, and cardiac complications has propelled this common condition into the spotlight as a major public health problem in the affected countries. Various enteroviruses cause HFMD, but the severe complications have been mostly associated with enterovirus 71 (EV71). Medical treatment is supportive and measures to interrupt transmission have been challenging to implement. Preventive vaccines could have an important clinical impact, especially among children younger than 3 years old who are most susceptible to the neurological complications. Several groups in the highly affected Asia-Pacific region are working towards vaccines against EV71 and some candidates have progressed to late-stage clinical trials with two vaccines recently reported to have been approved by the regulatory authorities in China. This report summarizes current issues and progress in the development of vaccines against EV71.",
    "author_highlights": [
        {
            "endOffset": 4901,
            "sentence": "EV71 Hand, Foot, and Mouth Disease is associated with life-threatening systemic complications.",
            "startOffset": 4807
        },
        {
            "endOffset": 4984,
            "sentence": "China recently licensed two highly efficacious formalin-inactivated EV71 vaccines.",
            "startOffset": 4902
        },
        {
            "endOffset": 5131,
            "sentence": "There is no cross-strain protection with currently available vaccines; thus, prompting the pursuit of more complex multivalent vaccine candidates.",
            "startOffset": 4985
        }
    ],
    "bib_entries": {
        "bib0135": {
            "authors": [
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Solomon"
                },
                {
                    "first": "Penny",
                    "initial": "P.",
                    "last": "Lewthwaite"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Perera"
                },
                {
                    "first": "Mary Jane",
                    "initial": "M.J.",
                    "last": "Cardosa"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "McMinn"
                },
                {
                    "first": "Mong How",
                    "initial": "M.H.",
                    "last": "Ooi"
                }
            ],
            "doi": "10.1016/S1473-3099(10)70194-8",
            "firstpage": "778",
            "issn": "14733099",
            "lastpage": "790",
            "pmid": "20961813",
            "pub_year": 2010,
            "title": "Virology, epidemiology, pathogenesis, and control of enterovirus 71",
            "volume": "10"
        },
        "bib0140": null,
        "bib0145": {
            "authors": [
                {
                    "first": "N. J.",
                    "initial": "N.J.",
                    "last": "Schmidt"
                },
                {
                    "first": "E. H.",
                    "initial": "E.H.",
                    "last": "Lennette"
                },
                {
                    "first": "H. H.",
                    "initial": "H.H.",
                    "last": "Ho"
                }
            ],
            "doi": "10.1093/infdis/129.3.304",
            "firstpage": "304",
            "issn": "00221899",
            "lastpage": "309",
            "pmid": "4361245",
            "pub_year": 1974,
            "title": "An apparently new enterovirus isolated from patients with disease of the central nervous system",
            "volume": "129"
        },
        "bib0150": {
            "authors": [
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Zhen",
                    "initial": "Z.",
                    "last": "Zhu"
                },
                {
                    "first": "Weizhong",
                    "initial": "W.",
                    "last": "Yang"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Ren"
                },
                {
                    "first": "Xiaojuan",
                    "initial": "X.",
                    "last": "Tan"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Naiying",
                    "initial": "N.",
                    "last": "Mao"
                },
                {
                    "first": "Songtao",
                    "initial": "S.",
                    "last": "Xu"
                },
                {
                    "first": "Shuangli",
                    "initial": "S.",
                    "last": "Zhu"
                },
                {
                    "first": "Aili",
                    "initial": "A.",
                    "last": "Cui"
                },
                {
                    "first": "Yong",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Dongmei",
                    "initial": "D.",
                    "last": "Yan"
                },
                {
                    "first": "Qun",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Xiaoping",
                    "initial": "X.",
                    "last": "Dong"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Yueping",
                    "initial": "Y.",
                    "last": "Zhao"
                },
                {
                    "first": "Junfeng",
                    "initial": "J.",
                    "last": "Wan"
                },
                {
                    "first": "Zijian",
                    "initial": "Z.",
                    "last": "Feng"
                },
                {
                    "first": "Junling",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "Shiwen",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Dexin",
                    "initial": "D.",
                    "last": "Li"
                },
                {
                    "first": "Wenbo",
                    "initial": "W.",
                    "last": "Xu"
                }
            ],
            "doi": "10.1186/1743-422X-7-94",
            "issn": "1743422X",
            "pmid": "20459851",
            "pub_year": 2010,
            "title": "An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China",
            "volume": "7"
        },
        "bib0155": {
            "authors": [
                {
                    "first": "Min Shi",
                    "initial": "M.S.",
                    "last": "Lee"
                },
                {
                    "first": "Fan Chen",
                    "initial": "F.C.",
                    "last": "Tseng"
                },
                {
                    "first": "Jen Ren",
                    "initial": "J.R.",
                    "last": "Wang"
                },
                {
                    "first": "Chia Yu",
                    "initial": "C.Y.",
                    "last": "Chi"
                },
                {
                    "first": "Pele",
                    "initial": "P.",
                    "last": "Chong"
                },
                {
                    "first": "Ih Jen",
                    "initial": "I.J.",
                    "last": "Su"
                }
            ],
            "doi": "10.1371/journal.pntd.0001737",
            "issn": "19352727",
            "pmid": "22953003",
            "pub_year": 2012,
            "title": "Challenges to Licensure of Enterovirus 71 Vaccines",
            "volume": "6"
        },
        "bib0160": {
            "authors": [
                {
                    "first": "Li W.",
                    "initial": "L.W.",
                    "last": "Ang"
                },
                {
                    "first": "Meng C.",
                    "initial": "M.C.",
                    "last": "Phoon"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Jeffery",
                    "initial": "J.",
                    "last": "Cutter"
                },
                {
                    "first": "Lyn",
                    "initial": "L.",
                    "last": "James"
                },
                {
                    "first": "Vincent T.",
                    "initial": "V.T.",
                    "last": "Chow"
                }
            ],
            "doi": "10.1186/1471-2334-11-270",
            "issn": "14712334",
            "pmid": "21988931",
            "pub_year": 2011,
            "title": "The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore",
            "volume": "11"
        },
        "bib0165": {
            "authors": [
                {
                    "first": "Min Shi",
                    "initial": "M.S.",
                    "last": "Lee"
                },
                {
                    "first": "Pai Shan",
                    "initial": "P.S.",
                    "last": "Chiang"
                },
                {
                    "first": "Shu Ting",
                    "initial": "S.T.",
                    "last": "Luo"
                },
                {
                    "first": "Mei Liang",
                    "initial": "M.L.",
                    "last": "Huang"
                },
                {
                    "first": "Guan Yuan",
                    "initial": "G.Y.",
                    "last": "Liou"
                },
                {
                    "first": "Kuo Chien",
                    "initial": "K.C.",
                    "last": "Tsao"
                },
                {
                    "first": "Tzou Yien",
                    "initial": "T.Y.",
                    "last": "Lin"
                }
            ],
            "doi": "10.1371/journal.pntd.0001476",
            "issn": "19352727",
            "pmid": "22348156",
            "pub_year": 2012,
            "title": "Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in taiwan, 2008-09",
            "volume": "6"
        },
        "bib0170": {
            "authors": [
                {
                    "first": "Chau Bich Nguyen",
                    "initial": "C.B.N.",
                    "last": "Tran"
                },
                {
                    "first": "Hieu Trong",
                    "initial": "H.T.",
                    "last": "Nguyen"
                },
                {
                    "first": "Ha Thanh Thi",
                    "initial": "H.T.T.",
                    "last": "Phan"
                },
                {
                    "first": "Ngoc",
                    "initial": "N.",
                    "last": "van Tran"
                },
                {
                    "first": "Bridget",
                    "initial": "B.",
                    "last": "Wills"
                },
                {
                    "first": "Jeremy",
                    "initial": "J.",
                    "last": "Farrar"
                },
                {
                    "first": "Joseph D.",
                    "initial": "J.D.",
                    "last": "Santangelo"
                },
                {
                    "first": "Cameron P.",
                    "initial": "C.P.",
                    "last": "Simmons"
                }
            ],
            "doi": "10.1371/journal.pone.0021116",
            "issn": "19326203",
            "pmid": "21765891",
            "pub_year": 2011,
            "title": "The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam",
            "volume": "6"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Mong How",
                    "initial": "M.H.",
                    "last": "Ooi"
                },
                {
                    "first": "See Chang",
                    "initial": "S.C.",
                    "last": "Wong"
                },
                {
                    "first": "Anand",
                    "initial": "A.",
                    "last": "Mohan"
                },
                {
                    "first": "Yuwana",
                    "initial": "Y.",
                    "last": "Podin"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Perera"
                },
                {
                    "first": "Daniella",
                    "initial": "D.",
                    "last": "Clear"
                },
                {
                    "first": "Sylvia",
                    "initial": "S.",
                    "last": "del Sel"
                },
                {
                    "first": "Chae Hee",
                    "initial": "C.H.",
                    "last": "Chieng"
                },
                {
                    "first": "Phaik Hooi",
                    "initial": "P.H.",
                    "last": "Tio"
                },
                {
                    "first": "Mary Jane",
                    "initial": "M.J.",
                    "last": "Cardosa"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Solomon"
                }
            ],
            "doi": "10.1186/1471-2334-9-3",
            "issn": "14712334",
            "pmid": "19152683",
            "pub_year": 2009,
            "title": "Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak",
            "volume": "9"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Hsiao Kuo",
                    "initial": "H.K.",
                    "last": "Lu"
                },
                {
                    "first": "Tzou Yien",
                    "initial": "T.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Shao Hsuan",
                    "initial": "S.H.",
                    "last": "Hsia"
                },
                {
                    "first": "Cheng Hsun",
                    "initial": "C.H.",
                    "last": "Chiu"
                },
                {
                    "first": "Yhu Chering",
                    "initial": "Y.C.",
                    "last": "Huang"
                },
                {
                    "first": "Kuo Chien",
                    "initial": "K.C.",
                    "last": "Tsao"
                },
                {
                    "first": "Luan Yin",
                    "initial": "L.Y.",
                    "last": "Chang"
                }
            ],
            "firstpage": "82",
            "issn": "16841182",
            "lastpage": "87",
            "pmid": "15181488",
            "pub_year": 2004,
            "title": "Prognostic implications of myoclonic jerk in children with enterovirus infection",
            "volume": "37"
        },
        "bib0185": null,
        "bib0190": {
            "authors": [
                {
                    "first": "Holger F.",
                    "initial": "H.F.",
                    "last": "Rabenau"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Richter"
                },
                {
                    "first": "Hans Wilhelm",
                    "initial": "H.W.",
                    "last": "Doerr"
                }
            ],
            "doi": "10.1007/s00430-009-0133-6",
            "firstpage": "45",
            "issn": "03008584",
            "lastpage": "51",
            "pmid": "19941005",
            "pub_year": 2010,
            "title": "Hand, foot and mouth disease: Seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany",
            "volume": "199"
        },
        "bib0195": {
            "authors": [
                {
                    "first": "Sabine",
                    "initial": "S.",
                    "last": "Diedrich"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Weinbrecht"
                },
                {
                    "first": "Eckart",
                    "initial": "E.",
                    "last": "Schreier"
                }
            ],
            "doi": "10.1007/s00705-009-0413-x",
            "firstpage": "1139",
            "issn": "03048608",
            "lastpage": "1142",
            "pmid": "19506798",
            "pub_year": 2009,
            "title": "Seroprevalence and molecular epidemiology of enterovirus 71 in Germany",
            "volume": "154"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "Wen Chan",
                    "initial": "W.C.",
                    "last": "Huang"
                },
                {
                    "first": "Wei Liang",
                    "initial": "W.L.",
                    "last": "Shih"
                },
                {
                    "first": "Shun Cheng",
                    "initial": "S.C.",
                    "last": "Yang"
                },
                {
                    "first": "Ting Yu",
                    "initial": "T.Y.",
                    "last": "Yen"
                },
                {
                    "first": "Jian Te",
                    "initial": "J.T.",
                    "last": "Lee"
                },
                {
                    "first": "Yi Chuan",
                    "initial": "Y.C.",
                    "last": "Huang"
                },
                {
                    "first": "Chung Chen",
                    "initial": "C.C.",
                    "last": "Li"
                },
                {
                    "first": "Yu Chia",
                    "initial": "Y.C.",
                    "last": "Hsieh"
                },
                {
                    "first": "Tzou Yin",
                    "initial": "T.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Luan Yin",
                    "initial": "L.Y.",
                    "last": "Chang"
                },
                {
                    "first": "Li Min",
                    "initial": "L.M.",
                    "last": "Huang"
                }
            ],
            "doi": "10.1016/j.jmii.2014.11.013",
            "firstpage": "10",
            "issn": "16841182",
            "lastpage": "16",
            "pmid": "25678038",
            "pub_year": 2017,
            "title": "Predicting severe enterovirus 71 infection: Age, comorbidity, and parental behavior matter",
            "volume": "50"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Feng Cai",
                    "initial": "F.C.",
                    "last": "Zhu"
                },
                {
                    "first": "Zheng Lun",
                    "initial": "Z.L.",
                    "last": "Liang"
                },
                {
                    "first": "Fan Yue",
                    "initial": "F.Y.",
                    "last": "Meng"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Zeng"
                },
                {
                    "first": "Qun Ying",
                    "initial": "Q.Y.",
                    "last": "Mao"
                },
                {
                    "first": "Kai",
                    "initial": "K.",
                    "last": "Chu"
                },
                {
                    "first": "Xue Fang",
                    "initial": "X.F.",
                    "last": "Song"
                },
                {
                    "first": "Xin",
                    "initial": "X.",
                    "last": "Yao"
                },
                {
                    "first": "Jing Xin",
                    "initial": "J.X.",
                    "last": "Li"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Ji"
                },
                {
                    "first": "Yi Ju",
                    "initial": "Y.J.",
                    "last": "Zhang"
                },
                {
                    "first": "Liang",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Hong Xing",
                    "initial": "H.X.",
                    "last": "Pan"
                },
                {
                    "first": "Ke",
                    "initial": "K.",
                    "last": "Xu"
                },
                {
                    "first": "Wei Ming",
                    "initial": "W.M.",
                    "last": "Dai"
                },
                {
                    "first": "Wei Wei",
                    "initial": "W.W.",
                    "last": "Zhang"
                },
                {
                    "first": "Fei",
                    "initial": "F.",
                    "last": "Deng"
                },
                {
                    "first": "Hua",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Jun Zhi",
                    "initial": "J.Z.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1371/journal.pone.0037206",
            "issn": "19326203",
            "pmid": "22662137",
            "pub_year": 2012,
            "title": "Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in Prenatal women and their infants",
            "volume": "7"
        },
        "bib0215": null,
        "bib0220": {
            "authors": [
                {
                    "first": "Feng Cai",
                    "initial": "F.C.",
                    "last": "Zhu"
                },
                {
                    "first": "Fan Yue",
                    "initial": "F.Y.",
                    "last": "Meng"
                },
                {
                    "first": "Jing Xin",
                    "initial": "J.X.",
                    "last": "Li"
                },
                {
                    "first": "Xiu Ling",
                    "initial": "X.L.",
                    "last": "Li"
                },
                {
                    "first": "Qun Ying",
                    "initial": "Q.Y.",
                    "last": "Mao"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Tao"
                },
                {
                    "first": "Yun Tao",
                    "initial": "Y.T.",
                    "last": "Zhang"
                },
                {
                    "first": "Xin",
                    "initial": "X.",
                    "last": "Yao"
                },
                {
                    "first": "Kai",
                    "initial": "K.",
                    "last": "Chu"
                },
                {
                    "first": "Qing Hua",
                    "initial": "Q.H.",
                    "last": "Chen"
                },
                {
                    "first": "Yue Mei",
                    "initial": "Y.M.",
                    "last": "Hu"
                },
                {
                    "first": "Xing",
                    "initial": "X.",
                    "last": "Wu"
                },
                {
                    "first": "Pei",
                    "initial": "P.",
                    "last": "Liu"
                },
                {
                    "first": "Lin Yang",
                    "initial": "L.Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Fan",
                    "initial": "F.",
                    "last": "Gao"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "Yi Juan",
                    "initial": "Y.J.",
                    "last": "Chen"
                },
                {
                    "first": "Yu Ying",
                    "initial": "Y.Y.",
                    "last": "Dong"
                },
                {
                    "first": "Yong Chun",
                    "initial": "Y.C.",
                    "last": "Liang"
                },
                {
                    "first": "Nian Min",
                    "initial": "N.M.",
                    "last": "Shi"
                },
                {
                    "first": "Heng Ming",
                    "initial": "H.M.",
                    "last": "Ge"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Sheng Gen",
                    "initial": "S.G.",
                    "last": "Chen"
                },
                {
                    "first": "Xing",
                    "initial": "X.",
                    "last": "Ai"
                },
                {
                    "first": "Zhen Yu",
                    "initial": "Z.Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Yu Guo",
                    "initial": "Y.G.",
                    "last": "Ji"
                },
                {
                    "first": "Feng Ji",
                    "initial": "F.J.",
                    "last": "Luo"
                },
                {
                    "first": "Xiao Qin",
                    "initial": "X.Q.",
                    "last": "Chen"
                },
                {
                    "first": "Ya",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Li Wen",
                    "initial": "L.W.",
                    "last": "Zhu"
                },
                {
                    "first": "Zheng Lun",
                    "initial": "Z.L.",
                    "last": "Liang"
                },
                {
                    "first": "Xin Liang",
                    "initial": "X.L.",
                    "last": "Shen"
                }
            ],
            "doi": "10.1016/S0140-6736(13)61049-1",
            "firstpage": "2024",
            "issn": "01406736",
            "lastpage": "2032",
            "pub_year": 2013,
            "title": "Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial",
            "volume": "381"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Fengcai",
                    "initial": "F.",
                    "last": "Zhu"
                },
                {
                    "first": "Wenbo",
                    "initial": "W.",
                    "last": "Xu"
                },
                {
                    "first": "Jielai",
                    "initial": "J.",
                    "last": "Xia"
                },
                {
                    "first": "Zhenglun",
                    "initial": "Z.",
                    "last": "Liang"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Liu"
                },
                {
                    "first": "Xuefeng",
                    "initial": "X.",
                    "last": "Zhang"
                },
                {
                    "first": "Xiaojuan",
                    "initial": "X.",
                    "last": "Tan"
                },
                {
                    "first": "Ling",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Qunying",
                    "initial": "Q.",
                    "last": "Mao"
                },
                {
                    "first": "Junyu",
                    "initial": "J.",
                    "last": "Wu"
                },
                {
                    "first": "Yuemei",
                    "initial": "Y.",
                    "last": "Hu"
                },
                {
                    "first": "Tianjiao",
                    "initial": "T.",
                    "last": "Ji"
                },
                {
                    "first": "Lifei",
                    "initial": "L.",
                    "last": "Song"
                },
                {
                    "first": "Qi",
                    "initial": "Q.",
                    "last": "Liang"
                },
                {
                    "first": "Baomin",
                    "initial": "B.",
                    "last": "Zhang"
                },
                {
                    "first": "Qiang",
                    "initial": "Q.",
                    "last": "Gao"
                },
                {
                    "first": "Jingxin",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Shenyu",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Yuansheng",
                    "initial": "Y.",
                    "last": "Hu"
                },
                {
                    "first": "Shanru",
                    "initial": "S.",
                    "last": "Gu"
                },
                {
                    "first": "Jianhua",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Genhong",
                    "initial": "G.",
                    "last": "Yao"
                },
                {
                    "first": "Jianxiang",
                    "initial": "J.",
                    "last": "Gu"
                },
                {
                    "first": "Xushan",
                    "initial": "X.",
                    "last": "Wang"
                },
                {
                    "first": "Yuchun",
                    "initial": "Y.",
                    "last": "Zhou"
                },
                {
                    "first": "Changbiao",
                    "initial": "C.",
                    "last": "Chen"
                },
                {
                    "first": "Minglei",
                    "initial": "M.",
                    "last": "Zhang"
                },
                {
                    "first": "Minquan",
                    "initial": "M.",
                    "last": "Cao"
                },
                {
                    "first": "Junzhi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Hua",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Nan",
                    "initial": "N.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1056/NEJMoa1304923",
            "firstpage": "818",
            "issn": "00284793",
            "lastpage": "828",
            "pmid": "24571754",
            "pub_year": 2014,
            "title": "Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China",
            "volume": "370"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Rongcheng",
                    "initial": "R.",
                    "last": "Li"
                },
                {
                    "first": "Longding",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Zhaojun",
                    "initial": "Z.",
                    "last": "Mo"
                },
                {
                    "first": "Xuanyi",
                    "initial": "X.",
                    "last": "Wang"
                },
                {
                    "first": "Jielai",
                    "initial": "J.",
                    "last": "Xia"
                },
                {
                    "first": "Zhenglun",
                    "initial": "Z.",
                    "last": "Liang"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Yanping",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Qunying",
                    "initial": "Q.",
                    "last": "Mao"
                },
                {
                    "first": "Jingjing",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Jiang"
                },
                {
                    "first": "Chenghong",
                    "initial": "C.",
                    "last": "Dong"
                },
                {
                    "first": "Yanchun",
                    "initial": "Y.",
                    "last": "Che"
                },
                {
                    "first": "Teng",
                    "initial": "T.",
                    "last": "Huang"
                },
                {
                    "first": "Zhiwei",
                    "initial": "Z.",
                    "last": "Jiang"
                },
                {
                    "first": "Zhongping",
                    "initial": "Z.",
                    "last": "Xie"
                },
                {
                    "first": "Lichun",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Yun",
                    "initial": "Y.",
                    "last": "Liao"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Liang"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Nong"
                },
                {
                    "first": "Jiansheng",
                    "initial": "J.",
                    "last": "Liu"
                },
                {
                    "first": "Hongling",
                    "initial": "H.",
                    "last": "Zhao"
                },
                {
                    "first": "Ruixiong",
                    "initial": "R.",
                    "last": "Na"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Guo"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Pu"
                },
                {
                    "first": "Erxia",
                    "initial": "E.",
                    "last": "Yang"
                },
                {
                    "first": "Le",
                    "initial": "L.",
                    "last": "Sun"
                },
                {
                    "first": "Pingfang",
                    "initial": "P.",
                    "last": "Cui"
                },
                {
                    "first": "Haijing",
                    "initial": "H.",
                    "last": "Shi"
                },
                {
                    "first": "Junzhi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Qihan",
                    "initial": "Q.",
                    "last": "Li"
                }
            ],
            "doi": "10.1056/NEJMoa1303224",
            "firstpage": "829",
            "issn": "00284793",
            "lastpage": "837",
            "pmid": "24571755",
            "pub_year": 2014,
            "title": "An inactivated enterovirus 71 vaccine in healthy children",
            "volume": "370"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Angela R.",
                    "initial": "A.R.",
                    "last": "Wateska"
                },
                {
                    "first": "Rachel R.",
                    "initial": "R.R.",
                    "last": "Bailey"
                },
                {
                    "first": "Julie H.Y.",
                    "initial": "J.H.Y.",
                    "last": "Tai"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Smith"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.09.065",
            "firstpage": "7731",
            "issn": "0264410X",
            "lastpage": "7736",
            "pmid": "20923711",
            "pub_year": 2010,
            "title": "Forecasting the economic value of an Enterovirus 71 (EV71) vaccine",
            "volume": "28"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Pele",
                    "initial": "P.",
                    "last": "Chong"
                },
                {
                    "first": "Chia Chyi",
                    "initial": "C.C.",
                    "last": "Liu"
                },
                {
                    "first": "Yen Hung",
                    "initial": "Y.H.",
                    "last": "Chow"
                },
                {
                    "first": "Ai Hsiang",
                    "initial": "A.H.",
                    "last": "Chou"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Klein"
                }
            ],
            "doi": "10.1093/cid/ciu852",
            "firstpage": "797",
            "issn": "10584838",
            "lastpage": "803",
            "pmid": "25352588",
            "pub_year": 2015,
            "title": "Review of enterovirus 71 vaccines",
            "volume": "60"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Yu Li",
                    "initial": "Y.L.",
                    "last": "Lin"
                },
                {
                    "first": "Chun I.",
                    "initial": "C.I.",
                    "last": "Yu"
                },
                {
                    "first": "Yu Chen",
                    "initial": "Y.C.",
                    "last": "Hu"
                },
                {
                    "first": "Tze Jiun",
                    "initial": "T.J.",
                    "last": "Tsai"
                },
                {
                    "first": "Yin Chieh",
                    "initial": "Y.C.",
                    "last": "Kuo"
                },
                {
                    "first": "Wei Kuang",
                    "initial": "W.K.",
                    "last": "Chi"
                },
                {
                    "first": "Ae Ning",
                    "initial": "A.N.",
                    "last": "Lin"
                },
                {
                    "first": "Bor Luen",
                    "initial": "B.L.",
                    "last": "Chiang"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.12.081",
            "firstpage": "1305",
            "issn": "0264410X",
            "lastpage": "1312",
            "pmid": "22214888",
            "pub_year": 2012,
            "title": "Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles",
            "volume": "30"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Weijia",
                    "initial": "W.",
                    "last": "Xing"
                },
                {
                    "first": "Qiaohong",
                    "initial": "Q.",
                    "last": "Liao"
                },
                {
                    "first": "C\u00e9cile",
                    "initial": "C.",
                    "last": "Viboud"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Junling",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "Joseph T.",
                    "initial": "J.T.",
                    "last": "Wu"
                },
                {
                    "first": "Zhaorui",
                    "initial": "Z.",
                    "last": "Chang"
                },
                {
                    "first": "Fengfeng",
                    "initial": "F.",
                    "last": "Liu"
                },
                {
                    "first": "Vicky J.",
                    "initial": "V.J.",
                    "last": "Fang"
                },
                {
                    "first": "Yingdong",
                    "initial": "Y.",
                    "last": "Zheng"
                },
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Cowling"
                },
                {
                    "first": "Jay K.",
                    "initial": "J.K.",
                    "last": "Varma"
                },
                {
                    "first": "Jeremy J.",
                    "initial": "J.J.",
                    "last": "Farrar"
                },
                {
                    "first": "Gabriel M.",
                    "initial": "G.M.",
                    "last": "Leung"
                },
                {
                    "first": "Hongjie",
                    "initial": "H.",
                    "last": "Yu"
                }
            ],
            "doi": "10.1016/S1473-3099(13)70342-6",
            "firstpage": "308",
            "issn": "14733099",
            "lastpage": "318",
            "pmid": "24485991",
            "pub_year": 2014,
            "title": "Hand, foot, and mouth disease in China, 2008-12: An epidemiological study",
            "volume": "14"
        }
    },
    "body_text": [
        {
            "endOffset": 18294,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Recently, the WHO ECBS approved a joint initiative between the National Institutes for Food and Drug Control and National Institute for Biological Standards and Control to develop quantitative standards for detecting EV71 neutralizing antibodies and antigens with the purpose of developing candidate vaccines.",
            "startOffset": 17985,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 20143,
            "parents": [],
            "refoffsets": {
                "bib0240": {
                    "endOffset": 20142,
                    "startOffset": 20138
                }
            },
            "secId": "sec0010",
            "sentence": "The use of an EV71 vaccine may impact natural transmission of wild EV71 virus and change its epidemiological characteristics [22].",
            "startOffset": 20013,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 23891,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Experimental animal model immunization and challenge studies have indicated that VLPs can generate protective neutralizing antibodies.",
            "startOffset": 23757,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 24313,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Live attenuated recombinant subunits, peptides and DNA approaches been described in the literature but to our knowledge these approaches are not being pursued by vaccine developers.",
            "startOffset": 24132,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 14409,
            "parents": [],
            "secId": "sec0005",
            "sentence": "All three have developed vaccines based on the inactivated whole virus approach, similar to the polio vaccine.",
            "startOffset": 14299,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 17232,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Additional constraints on EV71 vaccine development include the lack of an appropriate animal model, the need for more knowledge on virus transmission, epidemiology and disease burden, and an assessment of health care burden and costs for the prevention, treatment and control of an HFMD epidemic.",
            "startOffset": 16936,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 13266,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The epidemiologic correlation between maternal antibody titers and risk of HFMD suggests definable correlates of protection that can be induced by vaccines.",
            "startOffset": 13110,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21358,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Although the legacy of the polio vaccines may provide lessons for combination vaccine approaches, there will be additional technical and regulatory requirements that will need to be taken into account.",
            "startOffset": 21157,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24131,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Most of these efforts are currently in the preclinical stages.",
            "startOffset": 24069,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 15017,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As expected from previous preclinical studies, the vaccines that have been developed, thus far do not demonstrate any evidence of cross-protection across enterovirus species.",
            "startOffset": 14843,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 25102,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Improved understanding of the epidemiology and transmission dynamics of EV71 specifically and other HFMD-causing enteroviruses generally is needed to power efficacy trials as well as to assess vaccine impact.",
            "startOffset": 24894,
            "title": "Summary"
        },
        {
            "endOffset": 23756,
            "parents": [],
            "secId": "sec0015",
            "sentence": "An alternate to the inactivated virus approach is the development of VLP vaccines, which offer the advantage of presenting all surface epitopes of the EV71 capsid proteins (VP0, VP1, and VP3) in their native conformations at once.",
            "startOffset": 23526,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 15673,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Thus, for every episode of EV71, there were 11 episodes of CA16.",
            "startOffset": 15609,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 22198,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The three groups in mainland China that have developed inactivated whole virus vaccines benefited from the priority placed by the Chinese government on developing an EV71-HFMD vaccine in the aftermath of the 2008 outbreaks.",
            "startOffset": 21975,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 19609,
            "parents": [],
            "secId": "sec0010",
            "sentence": "It is estimated that, based on rates and outcomes observed in these trials, immunization would be cost-effective.",
            "startOffset": 19496,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 19495,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Higher infection incidence and vaccine efficacy were observed in the cited Phase 3 efficacy trials.",
            "startOffset": 19396,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 23103,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The National Health Research Institute in Taiwan is producing an inactivated whole virus vaccine based on the B4 genotype vaccine strain.",
            "startOffset": 22966,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 23412,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Inviragen of Singapore completed Phase 1 testing of a vaccine based on the B3 subtype that also demonstrated immunogenicity.",
            "startOffset": 23288,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 20810,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The latter may be a viable approach to broadening coverage with the inclusion of multiple enterovirus species that cause HFMD.",
            "startOffset": 20684,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 15244,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As it happens, EV71 did not turn out to be the dominant cause of the HFMD outbreaks and that in two of the trials, and only a small proportion of the total HFMD cases were caused by EV71 when confirmed by laboratory diagnosis.",
            "startOffset": 15018,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20683,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Some groups are already moving toward the next step of vaccine development for HFMD, multivalent and combination vaccines.",
            "startOffset": 20561,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24068,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 24067,
                    "startOffset": 24063
                }
            },
            "secId": "sec0015",
            "sentence": "Importantly, studies have also demonstrated that neutralizing antibodies induced by vaccination were cross-reactive against multiple subtypes that were not in the vaccine [23].",
            "startOffset": 23892,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 13712,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In fact, following a large-scale epidemic in Bulgaria in 1975, an inactivated whole virus EV71 vaccine candidate was developed and produced in the former Soviet Union, using a similar manufacturing process as that for the inactivated poliovirus vaccine.",
            "startOffset": 13459,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 16565,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Formulating vaccination policy will be difficult, given the challenges in justifying clinical benefit in an HFMD epidemic where EV71 is not the dominant strain.",
            "startOffset": 16405,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 14298,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Three vaccine manufacturers from mainland China have completed Phase 3 efficacy trials and applied for licensure approval from the China Food and Drug Administration in the end of 2014.",
            "startOffset": 14113,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15774,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In contrast, in another trial, of the 594 cases of clinical HFMD, 155 (26%) were lab-confirmed EV71.",
            "startOffset": 15674,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 13458,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Additionally, the availability and success of vaccination campaigns against another enterovirus, poliovirus, provides strong evidence for the feasibility of developing a vaccine against EV71.",
            "startOffset": 13267,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21974,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Five candidate vaccines have reached clinical evaluation, all inactivated whole viruses.",
            "startOffset": 21886,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 23287,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The vaccine entered Phase I clinical trials in 2010 and showed the induction of 4-fold or greater rise in neutralization antibody titers in healthy adults after the first vaccination.",
            "startOffset": 23104,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 15903,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 15902,
                    "startOffset": 15898
                }
            },
            "secId": "sec0005",
            "sentence": "Although the vaccine was not cross-reactive against other subtypes, vaccine efficacy against clinical HFMD was 49% (39\u201356) [19].",
            "startOffset": 15775,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 16174,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 16173,
                    "startOffset": 16166
                },
                "bib0225": {
                    "endOffset": 16173,
                    "startOffset": 16166
                },
                "bib0230": {
                    "endOffset": 16173,
                    "startOffset": 16166
                }
            },
            "secId": "sec0005",
            "sentence": "All three vaccines were immunogenic, achieving geometric mean antibody titers of 165.8 (Sinovac; 400 U/two-dose), 170.6 (Chinese Academy Medical Sciences; 100 U/two-dose), and 325.3 (Beijing Vigoo; 320 U/two-dose) and inducing seroconversion in >90% of subjects [18\u201320].",
            "startOffset": 15904,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20013,
            "parents": [],
            "secId": "sec0010",
            "sentence": "In addition, given the epidemic nature of the condition, considerations will also have to be made for the use of these vaccines in outbreak settings and how their effectiveness would be subsequently evaluated.",
            "startOffset": 19804,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 16405,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Although neutralizing antibody titers waned through 8 months of follow-up post-boost, they remained stable between 8 and 14 months, were still higher than at baseline and were significantly higher than titers in the placebo group.",
            "startOffset": 16175,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 23526,
            "parents": [],
            "secId": "sec0015",
            "sentence": "No further progress has been reported on these candidates following completion of their Phase 1 trials (Table 1).",
            "startOffset": 23413,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 21156,
            "parents": [],
            "secId": "sec0010",
            "sentence": "However this will require additional characterization of the disease burden, pathogenic spectrum and virological and molecular features of additional enteroviral targets.",
            "startOffset": 20986,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 22346,
            "parents": [],
            "secId": "sec0015",
            "sentence": "This has led to a vaccine development agenda that is highly coordinated among national vaccine manufacturing agencies in the most affected regions.",
            "startOffset": 22199,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 24893,
            "parents": [],
            "secId": "sec0020",
            "sentence": "However, the lack of cross-species activity complicates vaccine introduction campaigns and could limit their acceptance for widespread implementation.",
            "startOffset": 24743,
            "title": "Summary"
        },
        {
            "endOffset": 17648,
            "parents": [],
            "secId": "sec0010",
            "sentence": "EV71 vaccines have been developed and tested outside the traditional drug and vaccine pipeline, which normally involves a mature regulatory infrastructure that has experience not only in the development and enforcement of quality control standards, but also in the conduct and review of clinical trial data and the drafting of policy on the introduction and use of novel vaccines.",
            "startOffset": 17268,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 17984,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Mainland China, Taiwan and Singapore have more limited experience in these areas, although there are ongoing efforts, particularly in mainland China by the Chinese Drug Administration, to develop reference standards in a transparent manner and harmonize local, regional and international quality control requirements for EV71 vaccines.",
            "startOffset": 17649,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 22622,
            "parents": [],
            "secId": "sec0015",
            "sentence": "With a fast-track provided by regulators, all three Chinese companies have been able advance rapidly from first-in-human studies to Phase 3 trials in less than 18 months and out of these, two have received regulatory approval to manufacture and market their vaccine in China.",
            "startOffset": 22347,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 14842,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Despite the demonstration of efficacy in these trials, an EV71 vaccine still runs into the challenge of preventing and controlling not just EV71-associated HFMD but all-cause clinical HFMD.",
            "startOffset": 14653,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20560,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Therefore, the laboratory-based surveillance system will have to be strengthened to adequately monitor prevalent strains and strain variation.",
            "startOffset": 20418,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24566,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Two vaccines have received regulatory approval and EV71-associated HFMD could become a vaccine-controllable disease in China.",
            "startOffset": 24441,
            "title": "Summary"
        },
        {
            "endOffset": 18413,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Similar to polio vaccines, neutralizing antibody titers may serve as a good correlate of protection for EV71 vaccines.",
            "startOffset": 18295,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 18800,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Furthermore, experience from polio vaccines also show that there is variability in the induction of neutralizing antibody responses that result from the several antigenic formats following the production of inactivated whole virus.",
            "startOffset": 18569,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 21885,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Most of the other approaches are at the stage of early or late preclinical development.",
            "startOffset": 21798,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 19803,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Policies on the use of these vaccines will also need to consider if and how the EV71 vaccine would be introduced into a government's national immunization program as well as catch-up campaigns.",
            "startOffset": 19610,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 20255,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Surveillance and monitoring will be required to determine disease rates in the aftermath of vaccine deployment.",
            "startOffset": 20144,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24742,
            "parents": [],
            "secId": "sec0020",
            "sentence": "As EV71 vaccine development in LMICs is aimed at protecting infants and children less than 5 years of age, the vaccines could be considered within the scope of GAVI's mission.",
            "startOffset": 24567,
            "title": "Summary"
        },
        {
            "endOffset": 15415,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 15414,
                    "startOffset": 15410
                }
            },
            "secId": "sec0005",
            "sentence": "Of the 1704 cases of HFMD diagnosed clinically over 12 months of follow-up in one of the Phase 3 trials, only 36 (2.1%) were confirmed as being associated with EV71 [18].",
            "startOffset": 15245,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 18568,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Two of the Phase 3 trials discussed previously provided evidence that neutralizing antibodies correlated with protection at levels titers of 1:16 to 1:32.",
            "startOffset": 18414,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 14112,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Following the emergence of EV71-associated HFMD as a serious public health problem in the Asia-Pacific region, several groups in mainland China, Taiwan, and Singapore, are pursuing the development of an EV71 vaccine.",
            "startOffset": 13896,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 25567,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Sentinext Therapeutics is developing a HFMD vaccine with an EV71 VLP at its core.",
            "startOffset": 25486,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 25316,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The development of HFMD vaccines that cover the multiple viral etiologies through multivalent approaches is underway and could expand the clinical and public health impact of the next-generation vaccines for HFMD.",
            "startOffset": 25103,
            "title": "Summary"
        },
        {
            "endOffset": 25485,
            "parents": [],
            "secId": "sec0025",
            "sentence": "MJC is the chief scientific officer of and has shares in Sentinext Therapeutics based in Penang, Malaysia.",
            "startOffset": 25379,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 13109,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 13108,
                    "startOffset": 13104
                }
            },
            "secId": "sec0005",
            "sentence": "Seroprevalence studies suggest that maternally-derived antibodies, like most other infectious diseases, play an important role in neonatal and early immunity, protecting infants from EV71 disease during the first months of life but wane after 6 months of age to a nadir at 7\u201312 months [16].",
            "startOffset": 12819,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 24440,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The three formalin-inactivated EV71 vaccines tested in Phase 3 trials in China have reported a high-degree of efficacy.",
            "startOffset": 24321,
            "title": "Summary"
        },
        {
            "endOffset": 13895,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 13802,
                    "startOffset": 13798
                }
            },
            "secId": "sec0005",
            "sentence": "The vaccine was tested in 1\u20134 year old children and found to be safe and immunogenic [17] but was not evaluated for clinical efficacy as no subsequent outbreaks occurred in Bulgaria.",
            "startOffset": 13713,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15608,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The remainder of etiologies included 33.9% (577 episodes) positive for CA16, 34.5% (588 episodes) positive for other enteroviruses and 29.5% (503 episodes) not associated with any enterovirus.",
            "startOffset": 15416,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 25378,
            "parents": [],
            "secId": "sec0025",
            "sentence": "ZR has no conflict of interest to declare.",
            "startOffset": 25336,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 20417,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Evaluation of EV71 epidemiology and pathogenicity will also have to take place in the context of HFMD as a whole in addition to HFMD specifically caused by EV71.",
            "startOffset": 20256,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 19395,
            "parents": [],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 19394,
                    "startOffset": 19390
                }
            },
            "secId": "sec0010",
            "sentence": "Although detailed cost-effectiveness analyses are not widely available, one study has suggested that routine EV71 vaccination in China, with a background incidence of 0.04%, may be cost-effective if vaccine efficacy is \u226570%, and the vaccine costs $25 or less, or if vaccine efficacy is \u226550% and the vaccine costs $10 or less [21].",
            "startOffset": 19065,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 14653,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Large, multi-center trials, Phase 3 trials (each enrolling more than 10,000 children), in either 6\u201335 month or 6\u201371 month age groups have shown similar safety and efficacy profiles, achieving more than 90% protection from EV71-associated HFMD.",
            "startOffset": 14410,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20985,
            "parents": [],
            "secId": "sec0010",
            "sentence": "This strategy is being pursued by several groups, some of whom are developing bivalent HFMD vaccines with either the inactivated whole viruses or virus like particles (VLPs).",
            "startOffset": 20811,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 22965,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Outside of mainland China, similar vaccines (e.g., inactivated EV71 virus in an alum adjuvant) are being developed in Taiwan and Singapore.",
            "startOffset": 22826,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 16935,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The results also underline the importance of CA16 in the HFMD disease burden: thus an effective HFMD vaccine might have to at least be bivalent.",
            "startOffset": 16791,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 22825,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The vaccine manufacturers are also working with the regulatory authorities to develop standards that will allow for the comparison of the potency and immunogenicity of the respective vaccine candidates.",
            "startOffset": 22623,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 21585,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Various approaches have been pursued in the research development pipeline for EV71 vaccines, including live attenuated viruses, inactivated whole viruses, VLPs, and recombinant protein subunits.",
            "startOffset": 21391,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 21797,
            "parents": [],
            "secId": "sec0015",
            "sentence": "As described earlier, the most advanced candidates are inactivated whole virus vaccines that have leveraged previous knowledge and experience from the development and manufacturing of inactivated polio vaccines.",
            "startOffset": 21586,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 16790,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Careful thought and preparation will be required to help parents and the public understand that while such vaccines might prevent severe or fatal HFMD, they may offer no protection against HFMD caused by other enteroviruses.",
            "startOffset": 16566,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 19065,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Therefore the development of reference reagents and establishment of harmonized assays that measure the consistency and potency of the vaccines are critical for the assessment of these vaccines not only in China but also by regulatory authorities in other regions.",
            "startOffset": 18801,
            "title": "Technical and regulatory assessment"
        }
    ],
    "docId": "S0264410X16002887",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "zahussain22@gmail.com",
                "first": "Zarifah",
                "initial": "Z.",
                "last": "Reed"
            },
            {
                "email": null,
                "first": "Mary Jane",
                "initial": "M.J.",
                "last": "Cardosa"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.02.077",
        "firstpage": "2967",
        "issn": "0264410X",
        "keywords": [
            "Coxsackievirus A16 (CA16)",
            "EV71 vaccine",
            "Enterovirus 71 (EV71)",
            "Hand, Foot, and Mouth Disease (HFMD)",
            "Neutralizing antibody"
        ],
        "lastpage": "2970",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Status of research and development of vaccines for enterovirus 71"
    }
}